Total Funding
56
53
Total FundingSeries C raised
Growth Score 56 in past quarter
-12 pts
Heat Score 53 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
35764
Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology.
- Stephanie Cavoores: Senior Clinical Field ManagerPast Role: Deep Blue Medical Advances, Director, Clinical Affairs
Amarpreet Sawhney: Founder, President and Chief Executive OfficerPast Role: Ocular Therapeutix, Founder, President and CEO
About the Company
Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology.
It is a Bedford, Massachusetts-based company. independently held firm with the major objective of developing next-generation liquid embolics for the radiology department. with early medical applications in peripheral
hemostasis and interventional oncology. The EmbraceTM Hydrogel Embolic System, the company's initial product, and persistent embolization in these clinical situations.
